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ABSTRACT 
The flavonoid quercetin is extensively studied for its antioxidant and chemopreventive properties. 
However the poor water-solubility, low stability and short half-life could restrict its use in skin care 
products and therapy. 
The present study is aimed to evaluate the potential of aminopropyl functionalized mesoporous 
silica nanoparticles (NH2-MSN) as topical carrier system for quercetin delivery. Thermo 
gravimetric analysis, X-ray diffraction, high resolution transmission electron microscopy, nitrogen 
adsorption isotherms, FT-IR spectroscopy, zeta potential measurements and differential scanning 
calorimetry allowed analyzing with great detail the organic-inorganic molecular interaction. 
The protective effect of this vehicle on UV-induced degradation of the flavonoid was investigated 
revealing a certain positive influence of the inclusion on the photostability over time. 
Epidermal accumulation and transdermal permeation of this molecule were ex vivo evaluated using 
porcine skin mounted on Franz diffusion cells. The inclusion complexation with the inorganic 
nanoparticles increased the penetration of quercetin into the skin after 24 h post-application without 
transdermal delivery.  
The effect of quercetin alone or given as complex with NH2-MSN on proliferation of JR8 human 
melanoma cells was evaluated by sulforhodamine B colorimetric proliferation assay. At a 
concentration 60 M the complex with NH2-MSN was more effective than quercetin alone, causing 
about 50% inhibition of cell proliferation. 
 
 
 
 
 
Keywords: NH2-MCM-41 nanoparticles, quercetin delivery, photostability, cytotoxicity, skin 
uptake  
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1. Introduction 
 
Flavonoids have recently attracted great interest because of their potential beneficial effects on 
human health: they are reported to have antiviral, anti-allergic, antiplatelet, anti-inflammatory, 
antitumor and antioxidant activities [1, 2]. Among flavonols, quercetin (3,5,7,3′,4′-
pentahydroxyflavone) is recognized as a strong antioxidant because it can chelate metals, scavenge 
oxygen free radicals [3, 4] and in vitro inhibits xanthine oxidase and lipid peroxidation [5-7]. 
In addition, quercetin has been shown to be able to counteract UV-induced oxidative skin damage 
following topical application to the skin. These facts coupled with its safety and natural origin make 
this molecule an attractive candidate for incorporation into personal care formulations [8]. In 
cultured cells quercetin, depending on the conditions of exposure, shows either antioxidant or pro-
oxidant effects [9]. Quercetin has also received greater attention as pro-apoptotic flavonoid with a 
specific and almost exclusive activity on tumor cell lines rather than normal, non-transformed cells 
[10]. 
Due to its antioxidant, antitumor and anti-inflammatory activity, quercetin has been studied 
extensively as a chemoprevention agent in several cancer models [11]. Several in vitro studies have 
shown consistent anticancer effects of quercetin in a variety of cancer cell lines and tumors, 
including U138MG (glioma) [12], HeLa (cervical cancer) [13], MDA-MB-453 (breast cancer) [14], 
HT-29 (colorectal xenografts) [15], myeloid leukemia [16] and oral cavity cancer [17]. 
As for the biochemical mechanism, recent studies have revealed that quercetin inhibits cell 
proliferation by causing apoptosis and/or cell cycle arrest [18, 19]. It has been shown that quercetin 
treatment causes cell cycle arrests such as G2/M arrest or G1 arrest in different cell types [20-22]. 
Moreover, quercetin-mediated apoptosis may result from the induction of stress proteins, disruption 
of microtubules and mitochondria, release of cytochrome c, and activation of caspases [23]. The 
ability of quercetin to interfere with different targets identified as hallmarks of cancer makes this 
molecule a multi-target inhibitor with pleiotropic and synergistic effects in tumor cells [11]. 
5 
 
However its poor water solubility, low stability and short half-life have so far hampered its 
introduction in therapy and clinical practices. 
To overcome these inconveniences the use of supramolecular structures as nanoparticles or 
microparticles was proposed. Specifically, quercetin was included in cyclodextrins [24], covalently 
conjugated into a polymethacrylic acid backbone [25] or entrapped in chitosan nanoparticles [26]  
and liposomes [27]. However, most of these strategies allow little control over the nanocarrier size 
and poor versatility. 
Recently the use of ordered mesoporous materials as drug delivery systems (DDS), firstly reported 
by Vallet-Regí et al. [28], has become increasingly popular, as testified by the abundant literature 
on  mesoporous silica nanoparticles (MSN) as DDS [29-32].  
The extremely high surface area, ordered porosity and tunable pore volume of this bioactive oxide 
are ideal properties for high drug loading and diffusion-driven gradual release [33-35]. In addition, 
it is possible to chemically modify the surface properties through covalent grafting of various 
organic functional groups to the free silanol groups [36]. 
Nevertheless, few papers report the employment of MCM-41-type mesoporous silica as carrier 
system for the topical delivery of active agents [37-40]. 
Mesoporous silica is expected to have relatively good stability and biocompatibility, even if its fate 
in physiological fluids and the actual effect on cells is still the object of many studies, especially 
when nanoparticles are employed [31, 41-48]. 
Our previous studies on Trolox
®
, quercetin and rutin, indicate that mesoporous silica is an 
innovative carrier suitable for topical application of antioxidants [39, 49, 50].  
In this study we report on the immobilization of quercetin in aminopropyl-functionalized MCM-41 
mesoporous silica nanoparticles. The quercetin-loading capacity has been determined either 
spectrophotometrically or by thermo gravimetric analysis (TGA). A particular attention has been 
devoted to the physico-chemical properties of the inclusion complex. Therefore several analytic 
techniques (XRD, HRTEM, N2 adsorption analysis, FT-IR spectroscopy, zeta potential 
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measurements and DSC) have been employed to characterize the nanoparticles before and after 
complexation. The quercetin diffusion through a cellulose membrane has been studied, and the 
photostability of the included molecule has been analyzed upon UV irradiation. With a view to a 
possible use of quercetin in topical formulations, based on its antioxidant and protective properties, 
an ex vivo study using Franz diffusion cells was performed to investigate the influence of the 
inclusion in silica nanoparticles on the skin uptake of quercetin. Moreover in vitro cytotoxicity on 
JR8 human melanoma cells was tested in order to evaluate the chemoprevention potential of this 
innovative nanosized complex, compared to that of free quercetin. 
 
 
2. Materials and methods 
 
2.1. Materials 
3,3’,4’,5,7-Pentahydroxyflavone dihydrate (Quercetin dihydrate, Q) n-cetyl-trimethylammonium 
bromide (CTAB), tetraethyl orthosilicate (TEOS), 3-aminopropyl triethoxysilane (APTES), 
isopropyl myristate, toluene, magnesium sulfate, sodium chloride, sodium azide, sulforhodamine B 
(SRB), RPMI-1640 medium, fetal calf serum, Tris buffered saline, trichloroacetic acid and 
antibiotics for cell cultures were purchased from Sigma-Aldrich (Milan, Italy). Methanol, absolute 
ethanol, acetic acid and sodium acetate were from Fluka (Milan, Italy). Potassium palmitoyl 
hydrolyzed wheat protein and glyceryl stearate and cetearyl alcohol (Phytocream
®
 2000) was from 
Sinerga (Pero, Milan, Italy). Cetearyl isononanoate (Tegosoft
® 
CI), caprylic/capric triglycerides 
(Tegosoft
®
 CT), dimethicone (Abil
®
 350) and glycerol were ACEF (Fiorenzuola D’Arda, Piacenza, 
Italy) products. Carbomer (Carbopol
®
 ETD 2001) was from Noveon (Brussels, Belgium), and PEG-
30 dipolyhydroxystearate (Arlacel
®
 P135) from Croda (Mortara, Pavia, Italy). 
JR8 human melanoma cells were kindly provided by Dr. Chiara Dianzani (University of Torino, 
Dipartimento di Scienza e Tecnologia del Farmaco, Torino, Italy). 
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2.2. Synthesis of MCM-41 nanoparticles 
Purely siliceous MCM-41 nanoparticles (MSN) were synthesized by optimizing a literature 
procedure, employing CTAB as the Structure Directing Agent (SDA) and TEOS as the silica source 
[51, 52]. SDA was removed by calcination at 550 °C, first under nitrogen and subsequently under 
oxygen flow. Aminopropyl-functionalized MCM-41 nanoparticles (NH2-MSN) were prepared by 
suspending 1.0 g of calcined MSN in 30 mL of toluene. Next, 0.6 mL of APTES were added drop-
wise and the mixture was allowed to reflux for 8 h. The reaction solution was centrifuged and the 
deposited gel washed first with ethanol and then with deionized water. The obtained white solid was 
filtered, washed with methanol and dried in vacuum. 
 
2.3. Quercetin loading 
Q inclusion complexes were prepared by impregnation method in 1/3, 1/1, 3/1 w/w ratio. Different 
aliquots (213.1 mg, 71.0 mg, 23.7 mg, respectively) of NH2-MSN, previously outgassed at 150 °C 
for 1 h to remove the adsorbed water, were added to 10.0 mL of saturated Q methanol solution (21 
mM). The mixtures were kept under magnetic stirring at room temperature (RT) for 24 h and, after 
centrifugation, each precipitate was dried under vacuum. As reference model, Q complex with non-
functionalized nanoparticles was also prepared by the same method in 1/1 w/w ratio. The resulting 
complexes are hereafter labeled as Q/MSN and Q/NH2-MSN. 
2.4. Quercetin analysis 
UV-Vis spectrophotometry calibration curves were obtained in different media with diluted Q 
solutions over the range 1.5-15.2×10
-5
 M. The molar extinction coefficient (ε) was 20432 M-1 (R2 = 
0.9985) in ethanol, 23551 M
-1
 (R
2
 = 0.9998) in methanol and 17416 M
-1
 (R
2
 = 0.9503) in 
ethanol/acetate buffer pH 5.0 (20/80). 
HPLC analysis was performed employing an apparatus (Shimadzu) consisting of a LC-6A pump 
unit control, a SPD-2A UV-Vis detector, a C-R3A chromatopac integrator and a RP-C18 column 
8 
 
(Waters, 150×4.6 mm; 5 µm). Q was eluted with a mixture of methanol/water/acetic acid (50/47/3 
v/v/v) and its flow rate was kept at 0.8 mL/min. The elution profile was monitored at 371 nm and 
the retention time of Q was about 4.5 min. The amount of Q in the samples was quantified, based on 
the standard curve generated by calculating HPLC peak area of pure Q (in ethanol ε was 2.50×1010 
M
-1
 (R
2
 = 0.9961), while in ethanol/acetate buffer pH 5.0 (80/20) was 5.35×10
10
 M
-1
 (R
2
 = 0.9994).  
 
2.5. Physico-chemical characterization 
 
2.5.1. Thermo gravimetric analysis 
A thermo gravimetric analysis (TGA) was carried out on a TAQ600 (TA Instruments) heating the 
samples at a rate of 10 °C min
-1
 from 30 to 1000 °C in a nitrogen flow. Before starting the 
measurements, samples were equilibrated at 30 °C. Once reached the final temperature an isotherm 
was run for 15 min in air, to burn carbonaceous residues from pyrolysis reactions. 
 
2.5.2. X-ray diffraction 
Powder X-ray diffraction (XRD) patterns were collected on a X’Pert Pro Bragg Brentano 
diffractometer (Philips) using Cu K radiation (40 mA and 45 kV), with a scan speed of 0.01° min-
1
.  
2.5.3. High Resolution Transmission Electron Microscopy 
High resolution transmission electron microscopy (HRTEM) observations were performed on a 
JEOL 3010 instrument operating at 300 kV. For the measurements, the powder was dispersed on a 
copper grid coated with a perforated carbon film. 
 
2.5.4. N2 adsorption analysis  
Specific surface area (SSA), pore volume and size were measured by N2 adsorption–desorption 
isotherms at -196 °C using ASAP 2020 gas-volumetric analyzer (Micromeritics). SSA was 
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calculated using the Brunauer-Emmet-Teller (BET) method, average pore size and volume were 
calculated on the adsorption branch of the isotherms according to the Barrett-Joyner-Halenda (BJH) 
method (Kruk-Jaroniec-Sayari equations). Prior to analyses, samples were outgassed at RT 
overnight. 
 
2.5.5. FT-IR spectroscopy 
Fourier transform infrared spectra (FT-IR) were recorded with Bruker IFS28 equipped with a MCT 
detector, working with resolution of 4 cm
-1
 over 64 scans. Samples were in the form of self-
supporting pellets suitable for transmission infrared experiments and were placed in a quartz cell 
equipped with KBr windows, designed for RT studies in vacuum and controlled atmosphere. Before 
FT-IR analysis the samples were outgassed at RT to remove physically adsorbed water and 
impurities. 
 
2.5.6. Zeta potential measurements 
Zeta potential measurements of MSN, NH2-MSN, Q/MSN_1/1 and Q/NH2-MSN_1/1 were 
performed by means of electrophoretic light scattering (ELS) (Zetasizer Nano-ZS, Malvern 
Instruments). Each system was suspended in ultra-filtered water (0.1 % w/v), sonicated for about 10 
min and then analyzed at 25 ± 0.1 °C. Zeta potential values were measured without altering the pH 
of the dispersion medium (7.0) and using the Smoluchowski equation; results are expressed as the 
mean ± S.D. of three runs. 
 
2.5.7. Differential scanning calorimetry 
Differential scanning calorimetry (DSC) analyses were performed on a DSC-7 power compensation 
thermal analyzer (Perkin Elmer), performing temperature calibration with indium as standard. 1-12 
mg of samples having the same amount of Q were loaded in aluminum pans and heated under 
nitrogen flow at a scanning speed of 10 °C min
-1
 from 100 to 350 °C. 
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2.6. Testing of complex properties 
 
2.6.1. Preparation of the emulsions 
The O/W emulsion was made by adding, under homogenization by IKA T25 Ultra-Turrax, the 
melted lipid phase composed of Phytocream
®
 2000, Tegosoft
® 
CI and Abil
®
 350 to a suspension of 
Carbopol
®
 ETD 2001 and glycerol in ultrapure water, previously heated at 80 °C. The obtained 
system cooled to RT was then added with either Q or the complex Q/NH2-MSN, previously 
dispersed in a small volume of ultrapure water. Finally, the pH was adjusted to 5.0 (Table S1). 
To prepare the W/O emulsion the ultrapure water was heated at about 80 °C and then added with 
glycerol and magnesium sulfate. Meanwhile, the lipid phase consisting of Arlacel
®
 P135, Tegosoft
®
 
CT and isopropyl myristate was weighed and melted on the hotplate without exceeding 60 °C. The 
aqueous phase was then slowly joined to the lipids homogenizing to obtain a homogeneous system. 
The emulsion was left to cool under slow mechanical stirring by paddle stirrer until it reached RT. 
For the addition of Q, either as such or complexed with NH2-MSN, the same procedure described 
for the O/W emulsion was followed. The pH was adjusted to 5.0 (Table S2).  
 
2.6.2. Quercetin transmembrane diffusion 
The diffusion of Q through a Servapor
®
 (12,000-14,000 MWCO, Serva Electrophoresis) cellulose 
dialysis membrane was investigated using a glass apparatus consisting of two horizontal cells each 
of 12 mL volume; the diffusion area was 2.92 cm
2
. As donor phase, Q, free or complexed with 
NH2-MSN, was dispersed in ethanol/acetate buffer mixture (20/80 v/v, pH 5.0) or in O/W emulsion 
to get 0.0034% w/w in the first and 0.0084% w/w in the latter system. The receiving phase was 
ethanol/acetate buffer (20/80 v/v, pH 5.0). At fixed times up to 24 h, an aliquot (0.3 mL) of the 
receiving phase was withdrawn, replaced with an equal volume of fresh medium, suitably diluted 
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and analyzed using the HPLC method previously described. The experiment was carried out in 
triplicate.  
 
2.6.3. Photodegradation study 
Irradiation tests were performed separately on pure Q and on Q/NH2-MSN_1/1 complex. The runs 
were carried out in the ethanol/acetate buffer (10/90 v/v, pH 5.0) and in the O/W emulsion at Q 
concentration of 0.0034% w/w and 0.0084% w/w, respectively.  
All the samples (10.0 mL) were placed at a distance of 10.0 cm from a G40T10E UVB lamp 
(Sankyo Denki) with 2.5×10
-4
 W cm
-2
 power irradiance. During illumination the samples were 
stirred by an IKA RO 5 multiple magnetic stirrer. At scheduled times up to 24 h, a fixed amount 
(200 µL) of each sample was withdrawn and properly diluted with ethanol for spectrophotometrical 
analysis. The photodegradation kinetics were studied by plotting the percentage of non-degraded Q 
as a function of irradiation time. The percentage of non-degraded Q was calculated as follows:  
 
% non-degraded Q = Ct/C0 x 100 
 
where C0 is the Q concentration at zero time while Ct is the Q concentration after a given irradiation 
time (t). The study was carried out in triplicate. 
 
2.6.4. Ex vivo experiments on porcine skin  
Transepidermal permeation and skin uptake were determined using vertical Franz diffusion cells 
and porcine skin. Skin slices were isolated with an Acculan Aesculap dermatome from the outer 
side of pig ears freshly obtained from a local slaughterhouse and then stored for at least 24 h at -18 
°C. Prior to each experiment, the excised skin was rinsed with normal saline solution and pre-
hydrated by floating it in 0.002% (w/v) sodium azide aqueous solution. The skin was then 
sandwiched between the two cells with the stratum corneum side upwards. The receptor chamber 
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was filled with 6 mL of normal saline solution/ethanol (85/15 v/v) mixture.  
An aliquot (500 μL) consisting of 0.091% w/v Q, free or complexed (Q/NH2-MSN_1/1), in 
ethanol/acetate buffer (20/80 v/v, pH 5.0) was applied to the skin surface (available diffusion area 
of 1.60 cm
2
). The same procedure was followed for the emulsion systems (O/W or W/O) containing 
0.27% w/w of flavonoid. The content of the receptor chamber, continuously stirred at 34  1 °C, 
was removed at appropriate intervals (1-24 h) for Q determination and the cell was immediately 
refilled with fresh receptor solution. At the end of the experiment, the application site of the skin 
was washed with normal saline solution (0.9% w/v sodium chloride) to remove the residual 
formulation on the surface. The skin was then cut with scalpel into small pieces and added with 
ethanol (2.0 mL) for Q extraction. After 24 h of magnetic stirring at RT, the resulting suspension 
was centrifuged and the supernatant was assayed by HPLC analysis. The skin uptake was expressed 
as Q amount vs skin diffusion area (μg/cm2). 
 
2.6.5. Cell proliferation assays 
Cell growth inhibition was evaluated in JR8 melanoma cell line by sulforhodamine B colorimetric 
proliferation assay (SRB assay) [53], modified by Vichai and Kirtikara [54]. JR8 cells were 
routinely grown in RPMI-1640 added with 10% (v/v) fetal calf serum, 1% (v/v) penicillin-
streptomycin, and maintained in standard conditions (37 °C, 5% CO2 and 95% humidity). 
For cell proliferation assays, Q, Q/NH2-MSN_1/1, NH2-MSN, MSN were pre-suspended in culture 
medium containing 1% (v/v) ethanol. Thirty thousand cells were seeded into 96-well plates. After 
24 h, cells were incubated for 72 h, in triplicate wells, with the following, all diluted in culture 
medium: i) 1, 10, 30, 60 µM Q; ii) Q/NH2-MSN_1/1 amounts, containing the same Q concentration 
as previously; iii) NH2-MSN and MSN in the same amounts present in the complex. 
Control cells were incubated with culture medium containing the same final concentration of 
ethanol (maximum concentration 0.5% v/v). 
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Incubation was stopped by addition of 0.1 mL/well of trichloroacetic acid (10% w/v solution). After 
1 h at 4 °C, plates were washed repeatedly with water. The plates were then air-dried and stained 
with a 0.1 mL/well of SRB solution (0.057% w/v in 1% v/v acetic acid) (Sigma) for 30 min. 
Unbound dye was washed out four times with 0.2 mL/well of acetic acid (1% v/v). The SRB dye 
within cells was solubilized with 0.2 mL/well of Tris buffered saline (10 mM, pH 10.5) and optical 
density (OD) was quantified photometrically (492 nm) using a microplate reader Titertek Multiskan 
Plus (ICN Biomedical). The cell growth was expressed as percentage (mean OD of treated 
cells/mean OD of control cells 100). 
 
 
3. Results and discussion 
 
Physico-chemical characterization  
In this research the applicability of MSN as matrices for the topical release of Q was studied. 
TGA was employed to measure the amount of functional groups (aminopropyl) and the final Q 
loading in the inclusion complexes. Typical thermograms of the Q/NH2-MSN complexes are 
reported in Fig. 1 together with those of the parent NH2-MSN and MSN materials. Comparison 
among the weight losses of the three types of materials allowed calculating the weight percentage of 
functional groups and included Q molecules, as described elsewhere [49, 50]. 
The loading capabilities of NH2-MSN with different w/w ratios are listed in Table 1; Q complex 
with non-functionalized MSN was also considered for sake of comparison. This comparison clearly 
indicates that the storage ability of MSN is much lower than that of modified NH2-MSN. However 
this property of NH2-MSN does not increase with the Q amount employed in the preparation (w/w 
ratio). These results demonstrated the significant contribution of the aminopropyl-functionalization 
to drug uptake. The calculated values are in good agreement with Q quantification by UV-Vis 
spectrophotometry after extraction with absolute methanol (Table 1). These data were double 
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checked by measuring the Q amount remained in the supernatant (not reported). On the basis of 
these findings it can be stated that the complexation by 1/1 w/w ratio gave the most satisfactory 
results, thus for sake of brevity, the results description will be focused on this Q/NH2-MSN 
complex.  
Fig. 2 reports the low angle XRD patterns of Q/NH2-MSN_1/1, NH2-MSN and the parent MSN. 
Bare MSN shows the typical peaks due to an ordered hexagonal network of mesopores. The 
intensity of the peaks decreases after functionalization and subsequent Q loading (curves b and c, 
respectively), as often observed for this kind of materials. This trend could be interpreted in terms 
of pores filling with functional groups and Q molecules, while preserving the mesoporous structure 
[49, 50]. 
The HRTEM image of Q/NH2-MSN_1/1 revealed the presence of nanosized mesoporous spheres, 
with an average particle size of ca. 250 (± 50) nm, characterized by regular and ordered channels 
with hexagonal symmetry (Fig. 3, Section A). The microscopic analyses confirmed that neither the 
grafting procedures nor the complexation phenomenon affected the structure and morphology of 
NH2-MSN. This can be appreciated in the high magnification image in Fig. 3, Section B. 
The low temperature nitrogen adsorption/desorption isotherms of the Q/NH2-MSN_1/1 and NH2-
MSN samples are reported in Fig. 4, together with that of the parent MSN for comparison. All 
samples show the type IV isotherm typical of mesoporous materials. The decrease in the amount of 
nitrogen adsorbed by MSN to NH2-MSN and Q/NH2-MSN_1/1 is a clear indication of SSA 
decrease (see Table 2). This is also accompanied by changes in the curves shape, which accounts 
for modification of pore size and available volume [49, 50]. The data, in agreement with the other 
characterization techniques described above, suggest the lining of the pores with aminopropyl 
groups and their filling with Q molecules. This suggests a relatively strong interaction between 
functionalized silica and Q molecules. 
FT-IR spectroscopy was employed to get information at the molecular level on the interaction of Q 
with the silica surface. The main vibrational modes of silica surface groups (silanols and 
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aminopropyls) and Q molecules are labeled in Fig. 5. A detailed analysis of the spectra (outside the 
scopes of this paper) confirms the presence and structural integrity of Q molecules within the silica 
pores. Moreover, changes in the position of Q vibrational modes (νC=O, aromatic νC=C and νC-
O/O-H combination modes, see Fig. 5) indicate hydrogen bonding interactions from the silica 
surface groups to the carbonyl of Q [55]. 
Regarding zeta potential measurements, as shown in Fig. S1, the value of MSN was -26.8 (± 0.56) 
mV, while it increased to +17.3 (± 0.46) mV after functionalization. This is because the silanol 
groups were negatively charged under a wide range pH conditions, while the aminopropyl groups 
attached on MSN were positively charged when suspended in water. This zeta potential variation 
well confirmed the successful functionalization of aminopropyl groups on MSN. 
Upon Q loading, the zeta potential of MSN changed from -26.8 to -19.0 (± 0.81) mV while that of 
NH2-MSN varied from +17.3 to +13.6 (± 0.16) mV indicating that probably antioxidant molecules, 
partially deposited on the surface of the silica nanoparticles, could shield their surface charge 
leading to decrease in zeta potential absolute values. 
The interaction of Q with the aminopropyl-functionalized silica surface was further verified by DSC 
technique (not reported). NH2-MSN did not display any peak while pure Q showed an intense 
endothermic peak at 321 °C characterized by H = 148 J/g and related to the melting process. 
However, in the flavonoid complex this endothermic peak was suppressed indicating the molecular 
dispersion of Q within the silica pores. No differences are remarked among the complexes prepared 
in different weight ratios, suggesting the partial protection due to the encapsulation of Q within 
mesoporous silica and an important Q/silica molecular interaction for all the tested complexes.  
 
Testing of complex properties 
Diffusion tests through a semi-permeable membrane were carried out in order to assess Q release 
from the mesoporous matrices in topical formulations.  
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Results are summarized in Fig. 6 in terms of diffusion rate. Data indicated that both in 
ethanol/acetate buffer (20/80 v/v, pH 5.0) and in O/W emulsion the diffusion from the complex was 
delayed compared to that obtained from free Q confirming that a certain interaction between the 
two species occurred. The diffusion followed a pseudo-zero order kinetics both for pure Q and for 
the complex although the slopes of the O/W emulsion are lower than those of the solution. Besides, 
in both the tested media the diffusion rate of Q from the complex was quite evident confirming that 
no-covalent bonds were involved in the complex formation. Moreover, Q -either free or complexed 
with NH2-MSN- diffused more slowly from O/W emulsion than from ethanol/acetate buffer, 
indicating that the polarity of the system can influence its release. Thus, it can be hypothesized that 
Q diffusion from complex is affected by both the dispersion system and the silica matrix. 
Antioxidants like flavonoids are frequently used in sunscreen formulations to complement UV filter 
photoprotection by preventing or reducing the damage from the free radicals generated by solar 
radiation [56]. Anyway the photochemical instability of Q represents a limitation for its potential 
applicability in suncare products. 
Initially investigations on the light-induced decomposition of Q were performed in an aqueous 
environment. Since Q is practically insoluble in water, it was solubilized in a hydroalcoholic 
solution of ethanol/acetate buffer (20/80, pH 5.0). The photodegradation curves were linearized and 
the rate equations are reported in Table 3. The percentage of the non-degraded flavonoid 24 h after 
UVB irradiation of the examined formulations was 52.6% for the non-encapsulated Q and 76.5% 
for the complexed one (Table 4). Although these studies provided valuable information on the 
photochemistry aspects, their relevance to the real conditions encountered in the use of topical 
preparations is limited. In order to overcome this drawback, in the present investigation the 
photochemical behavior of free and complexed Q was also examined using a cream (oil-in-water 
emulsion) as vehicle. This system was selected as a model formulation since it represents the most 
common type of topical preparation and hence reproduces the actual applicative conditions of 
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dermatological products. Moreover it was reported that Q photodegradation was observed in 
creams, unless protected in lipid droplets [57].  
In the present emulsion, pure Q showed a degradation of 11.7% meanwhile the complexed Q 
irradiated at the same conditions exhibited no meaningful alteration in the percentage content over 
the monitoring period. The molecular photostability of the Q is substantially enhanced compared to 
the solution samples stored in the same conditions, proving that the presence of a biphasic system 
could significantly increase the flavonoid photostability. It could be concluded from these findings 
that the simultaneous inclusion in NH2-MSN and the dispersion in an emulsion system would be an 
effective route to improve the stabilization of the chemical labile drugs. Q photostability is of 
crucial importance because it was demonstrate that among the hydroxyl groups in Q, those in 
position 3, 3’ and 4’ are mainly involved in the antioxidant activity of the compound, as well as in 
its photolability [58]. In this way not only Q stability increased but also antioxidant ability could 
noticeably be potentiated. 
 
Topical delivery of quercetin 
Due to the well-documented antioxidant properties of Q and its safety on normal cells, an utilize of 
this compound in topical formulations, as protective agent, could be envisaged. Although the active 
ingredient of pharmaceutical or personal care products is essential, the method and the vehicle in 
which it is delivered are crucial. Micro- and nanoparticulate systems, including microspheres and 
nanoparticles, are used to make substances more compatible with each other, to release the active in 
a controlled manner and also to protect from degradative phenomena. Some vehicles not only 
stabilize the active ingredients, but also enhance their delivery across skin. 
As a preliminary test for the possible use of these mesoporous nanoparticles as topical vectors for 
Q, an ex vivo study on porcine skin was performed. The choice of this model skin is due to its high 
affinity with the human one [59]. 
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The experiments were carried out employing either the hydroalcoholic solution (ethanol/acetate 
buffer (20/80 v/v, pH 5.0) or the W/O emulsion as dispersion system for the Q-loaded silica 
nanoparticles. The corresponding free Q formulations were examined as controls. 
Such studies are also relevant investigating topical drug delivery to make sure that none of the 
compounds appears to permeate transdermally. In our experiments, sampling was performed from 
the receptor media after 24 h to determine if there was a transdermal delivery of Q. All the studied 
systems showed a negligible transepidermal permeation; this observation is consistent with reports 
from other skin permeation studies of Q [60, 61]. 
The absence of transdermal delivery of Q can be attributed both to the barrier properties of the 
stratum corneum and to the structure and physico-chemical characteristics of this flavonoid. Indeed, 
one of the reasons contributing to the inability of Q to penetrate the skin could be its poor 
lipophilicity [62] and rather limited aqueous solubility [63]. 
Fig. 7 shows the amount of Q quantified in the skin 24 h after the application. Regarding free Q, 
different accumulation values were observed depending on the employed dispersion medium. 
Particularly, significant results were obtained with hydroalcoholic solution (3.36 µg/cm
2
) and even 
more with the W/O emulsion (4.77 µg/cm
2
). In contrast the accumulation observed from the O/W 
emulsion (data not shown) was almost negligible; therefore this system was excluded in the case of 
the complex sample. These results can be explained on the basis of the octanol-water partition 
coefficient (log P) of Q which is reported to be 1.82 thus unfavorable to water which is the external 
phase of this medium [64]. 
The silica-based formulations showed higher amounts of Q retained in the skin (9.79 µg/cm
2 
from 
hydroalcoholic solution and 10.89 µg/cm
2 
from W/O emulsion) compared to those containing free 
Q. The improved skin accumulation observed from the nanosized complex could derived from an 
increased contact surface with the corneocytes. Specifically, due to the electrostatic interaction with 
the negatively charged character of the cell membranes, the positive surface charge of the 
mesoporous nanocarriers could favour adhesion to the upper skin layers, prolonging the release and 
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enhancing the bioavailability of the included active molecule. All these reasons could contribute to 
the increased ability of Q immobilized in nanoparticles to greater accumulate into the skin, as 
already demonstrated in our previous study on rutin [49].  
Skin penetration and drug localization are the main goals of topically administered products. 
Nevertheless, the outer skin layer (stratum corneum) is characterized by a highly hydrophobic lipid 
matrix primarily consisting of ceramides, cholesterol and fatty acids and consequently it has the rare 
ability to block both the hydrophilic and hydrophobic penetrants. Ideally, topically applied 
formulations are designed to penetrate the skin to a certain degree, to achieve a significant residence 
time, and to deliver an active compound, all the while remaining non-irritating. 
Thus, particles must be rationally designed to penetrate beyond the stratum corneum and persist 
within the skin despite routine washing and natural skin sloughing. Small particle size has been 
indicated by several studies to increase penetration within skin models [65]. In particular, for 
nanoparticles, an enhanced follicular penetration has been described whereas intercellular 
penetration for larger particles is hardly realistic due to their size [66]. However, up to now, most of 
the studies assessing the skin penetration of different nanoparticle types after topical application 
have shown penetration of particles into upper layers of the skin but not deeper into the viable 
epidermis and dermis.  
Although we currently have no direct evidence for the localization of Q-loaded silica nanoparticles 
within the skin it can be reasonably suggested the feasibility of using this innovative carrier, 
especially vehicled in a W/O emulsion, to target active ingredients to corneocytes in order to 
prevent oxidative damages.  
 
Cytotoxicity study on JR8 cell line 
In addition to the antioxidant and scavenging ROS properties, that make Q suitable as skin 
protective in topical formulations, Q shows antiproliferative, cytotoxic, proapoptotic activities in a 
number of cancer cell lines of different origin (prostate, cervical, lung, breast, colon), included 
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melanoma cells [11-17]. 
Q is able to inhibit the growth and proliferation preferentially in cancer cells versus their normal 
counterparts through a process involving the down-regulation of selective oncogenes (such as Mcl-
1, Ras, MEK, PI3K), or the up-regulation of tumor suppressor genes (p53, p21), which, in turn, 
enhance selective pathways leading to the elimination of cancer cells. 
In order to check if the functionalized nanosized complex is a good delivery system of Q with the 
aim of inhibiting cell proliferation, the cytotoxic effect of the Q immobilized in silica nanoparticles, 
compared to free Q, was tested on a line of human melanoma cells. 
The JR8 human melanoma cells were incubated with different concentrations, in the range 1 to 60 
µM, of both free Q and Q/NH2-MSN_1/1 for 72 h and the cell proliferation was determined by SRB 
assay, a method developed by Skehan and colleagues in 1990 at the National Cancer Institute (NCI) 
for high-throughput drug screening to measure drug-induced cytotoxicity and cell proliferation. Its 
principle is based on the ability of the protein dye sulforhodamine B to bind to protein basic amino 
acid residues of trichloroacetic acid-fixed cells. SRB assay provides linearity with cell number, high 
sensitivity and the staining is not cell-line-dependent [53]. 
The cytotoxicity of free and NH2-MSN-complexed Q was compared with that of the same 
concentrations of both bare MSN and NH2-MSN. As shown in Fig. 8, the proliferation of JR8 
human melanoma cells was not affected by MSN and NH2-MSN at the highest concentrations 
tested, suggesting that the nanoparticles used in this study show absence of toxicity and good 
biocompatibility. Free Q and Q/NH2-MSN_1/1 complex at the lower tested concentration (1, 10, 30 
μM) did not influence cell proliferation. However, by increasing the concentration of Q to 60 µM, 
cell growth inhibition, compared to untreated controls, was noticed. At this concentration the cell 
proliferation was inhibited of about 15 and 50% when the cells were treated respectively with Q or 
Q/NH2-MSN_1/1. Our data are in agreement with the effect assessed in a different line of 
melanoma cells, the OCM-1, where a concentration 70 µM was found effective in blocking the 
proliferation and arresting cells at the G1 phase by inhibiting Cdk2 activity and up-regulating p27 
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and p21 [11]. 
Growth inhibition at concentrations ranging from 50 µM to 100 µM was also observed in different 
cancer cell lines [9, 67, 68], while the toxicity of Q in normal, non tumor cells, was detected at 
concentrations higher than 100 µM [10]. 
Our study underlines a higher cytotoxicity of Q when complexed with mesoporous silica 
nanoparticles, possibly due to a better release or cellular uptake by the nanosized system while the 
nanoparticles alone show no toxicity at higher concentration. 
The potential application of Q formulations in cancer chemoprevention is based on its ability of 
inhibiting cell proliferation of cancer cells rather than normal ones. Cancer cell lines appear more 
susceptible to cycle arrest and apoptosis at concentration that have no or little effect on non-
transformed cells. In this study a preliminary evaluation of cell growth inhibition by Q immobilized 
in NH2-MSN was made in JR8 melanoma cell line: the positive obtained results stimulate further 
studies on different cell lines, both normal and tumoral, aimed to a better understanding of the 
mechanism of these nanocarriers-induced effects on the regulation of tumor growth. 
 
 
CONCLUSIONS 
 
A novel approach to improve the topical delivery of Q by immobilization in NH2-MSN was 
demonstrated. 
Different techniques were employed to establish the host/guest interaction between this flavonoid 
and mesoporous silica nanoparticles. The influence of the functionalization of the inorganic matrix 
on the Q bioactivity was also investigated.  
The presence of aminopropyl groups lining the silica pores was confirmed by many characterization 
techniques, namely specific surface area and porosity analysis, XRD, TGA, HRTEM and zeta 
potential measurements. Q inclusion was determined both from a quantitative point of view (TGA, 
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spectrophotometric analysis) and from a molecular point of view by FT-IR spectroscopy. The latter 
proved the structural integrity of the molecules and gave hints on the hydrogen-bonding interaction 
of Q with the hybrid organic/inorganic surface. 
Transmembrane diffusion study confirmed a certain host/guest interaction. The immobilization in 
NH2-MSN improved the photostability of Q and the protective effect was more evident when the 
nanosized complex was dispersed in a biphasic system. The grafting of aminopropyl groups in the 
mesoporous silica resulted a valid strategy to increase Q penetration into the skin as can be deduced 
from the results obtained by the ex vivo porcine skin experiments.  
These positive findings indicate that NH2-MSN can be considered a potential topical carrier for 
encapsulating flavonoids derivatives improving their intrinsic stability and biological activity after 
topical application. 
The cytotoxicity studies, albeit very preliminary, show that these Q-loaded mesoporous 
nanoparticles appear a very promising approach to deliver flavonoids as chemopreventive agents 
into targeted organs and cells; particularly they showed both a good biocompatibility and the ability 
to increase the antiproliferative activity of Q. 
Since this is a preliminary screening study, in vivo testing needs to be conducted in future to 
demonstrate the applicability of this innovative delivery system.  
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Table 1. Data from thermogravimetric analysis (percentage weight loss) and from UV-Vis 
spectrophotometric analysis (percentage of loading, % wt Q) 
 
  Quercetin 
Samples Aminopropyl groups  TGA  UV-Vis  
MSN - - - 
NH2-MSN 10.2 - - 
Q/MSN_1/1 - 4.7 3.2 
Q/NH2-MSN_1/1 10.2 9.2 8.0 
Q/NH2-MSN_1/3 9.6 8.3 6.0 
Q/NH2-MSN_3/1 9.6 9.5 8.0 
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Table 2. Porosity and specific surface area of the silica based samples 
 
 
 
 
 
 
 
 
 
 
 
  
Samples 
Pore diameter 
(Å) 
SSA 
(m
2
·g
-1
) 
Pore Volume
 
 
(cm
3
·g
-1
) 
MSN 32 1216 1.98 
NH2-MSN 27 704 0.85 
Q/NH2-MSN_1/1 - 90 0.25 
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Table 3. Photodegradation equations of Q, free or complexed with silica in 1/1 w/w ratio, in 
ethanol/acetate buffer (20/80 v/v, pH 5.0) or in O/W emulsion (pH 5.0), upon UVB irradiation (24 
h). 
 
Samples Solution O/W emulsion 
Q y = -1.975x + 100.0 R
2
= 0.970 y = -0.467x + 99.5 R
2
= 0.995 
Q/NH2-MSN_1/1 y = -0.979x + 100.0 R
2
= 0.910 y = -0.049x + 100.1 R
2
= 0.963 
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Table 4. Percentage of non-degraded Q, free or complexed with silica in 1/1 w/w ratio, in 
ethanol/acetate buffer (20/80 v/v, pH 5.0) or in O/W emulsion (pH 5.0), upon UVB irradiation (24 
h). 
 
 % non-degraded Q 
Samples Solution O/W emulsion 
Q 52.6 (± 3.6) 88.3 (± 1.6) 
Q/NH2-MSN_1/1 76.5 (± 2.1) 98.9 (± 1.8) 
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Table S1. Percent composition of O/W emulsion 
 
Ingredients % wt 
Phytocream
® 
2000 2.5 
Tegosoft
® 
CI 6.5 
Abil
®
 350 1.0 
Carbopol
®
 ETD 2001 0.1 
Glycerol 4.5 
Water 85.4 
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Table S2. Percent composition of W/O emulsion 
 
Ingredients % wt 
Arlacel
® 
P135 2.0 
Tegosoft
® 
CT 9.0 
Isopropyl myristate  9.0 
Glycerol 4.0 
Magnesium sulfate 0.7 
Water 75.3 
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Figure captions: 
 
Scheme 1. Structure of quercetin molecule 
 
Fig. 1. Thermogravimetric analysis of MSN (a), NH2-MSN (b) and Q/NH2-MSN_1/1 (c). Weight 
losses were measured in N2 flow up to 1000 °C, and in air for a 15 min isotherm at the same 
temperature. 
 
Fig. 2. Powder XRD patterns of a MSN (a), NH2-MSN (b) and Q/ NH2-MSN_1/1 (c). 
 
Fig 3. Representative HRTEM images of the Q/NH2-MSN_1/1: 30000X (A); 120000X (B).  
 
Fig. 4. Nitrogen isotherm adsorption () and desorption () on MSN (a), NH2-MSN (b) and Q/NH2-
MSN_1/1 (c). 
 
Fig. 5. FT-IR spectra of NH2-MSN, Q/NH2-MSN_1/1 and free Q in the high and low frequency 
ranges (top and bottom, respectively). 
 
Fig. 6. Diffusion profiles of Q in ethanol/acetate buffer (20/80, pH 5.0) solution (black solid line, 
diamond), Q in O/W emulsion (black dotted line, square), Q/NH2-MSN_1/1 in ethanol/acetate 
buffer pH 5.0 (20/80) solution (grey solid line, triangle) and Q/NH2-MSN_1/1 in O/W emulsion 
(grey dotted line, cross) through the cellulose membrane. Each bar represents the mean ± SD 
obtained in three independent experiments. 
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Fig. 7. Ex vivo porcine skin accumulation values of free Q (black) and Q/NH2-MSN_1/1 (grey) 24 h 
after application on Franz diffusion cells from different media. Each bar represents the mean ± SD 
obtained in three independent experiments. 
 
Fig. 8. Effect of Q, Q/NH2-MSN_1/1, NH2-MSN and MSN on JR8 cell proliferation by SRB assay. 
Cells were incubated with the substances at different concentrations for 72 h. The concentration of 
silica nanoparticles is shown in the upper axis, while the concentration of Q, both free or 
complexed, is reported in the lower axis. Cell growth is expressed as % T/C (mean OD of treated 
cells/mean OD of control cells ×100). Values are mean ± SD (n=3 wells/condition) of two 
independent experiments. 
 
Fig. S1. Effect of aminopropyl functionalization and Q loading on zeta potential of MSN 
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Fig. 5 (top) 
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Fig. 5 (bottom) 
  
46 
 
 
Fig. 6 
  
47 
 
 
Fig. 7 
  
48 
 
 
Fig. 8 
  
49 
 
 
 
Fig. S1 
 
